我在国外，我放一段国外的英文，就当给各位打一针强心剂吧，别放弃，好好生活。
Current herpes vaccine candidates in clinical trials include: mRNA-1608 is an mRNA vaccine candidate against HSV-2 disease. The mRNA-1608-P101 phase 1 study launched on September 6, 2023, and is forecasted to be completed on June 4, 2025. With mRNA-1608, Moderna Inc.
